Home Newsfeeds UBS Downgrades Kellogg to Neutral, Lowers Price Target to $74

UBS Downgrades Kellogg to Neutral, Lowers Price Target to $74

UBS analyst Cody Ross downgrades Kellogg (NYSE:K) from Buy to Neutral and lowers the price target from $81 to $74.

byBenzinga Newsdesk

July 7, 2022

1 minute read

UBS analyst Cody Ross downgrades Kellogg (NYSE:K) from Buy to Neutral and lowers the price target from $81 to $74.

Morgan Stanley Maintains Equal-Weight on CME Group, Lowers Price Target to $213

By Benzinga Newsdesk

October 12, 9:59 AM

Morgan Stanley analyst Michael Cyprys maintains CME Group (NASDAQ:CME) with a Equal-Weight and lowers the price target from $226 to $213.

CME

Binance’s CZ Deletes Tweet On Coinbase Bitcoin Holdings After Armstrong Clears The Air, Crypto Twitter Erupts

By Mehab Qureshi

November 22, 10:47 PM

Binance CEO Changpeng "CZ" Zhao, stirred up controversy on Tuesday by tweeting about Coinbase Global's (NASDAQ: COIN) Bitcoin (CRYPTO: BTC) holdings.

BTC

After-Hours Alert: Why NXP Semiconductors Stock Is Sliding

By Adam Eckert

January 30, 5:43 PM

NXP Semiconductors N.V. (NASDAQ: NXPI) shares are trading lower in Monday's after-hours session after the company reported fourth-quarter financial results and issued weak guidance.

NXPI

What’s Going On With Cancer Drug-Developer Nkarta Stock?

By Erica Kollmann

January 8, 4:51 PM

Nkarta, Inc. (NASDAQ: NKTX) shares are blasting higher Monday, and the stock has gained more than 270% over the past month. Here's a look at what's going on.

NKTX

UBS Downgrades Kellogg to Neutral, Lowers Price Target to $74

Related Posts

Morgan Stanley Maintains Equal-Weight on CME Group, Lowers Price Target to $213

Binance’s CZ Deletes Tweet On Coinbase Bitcoin Holdings After Armstrong Clears The Air, Crypto Twitter Erupts

After-Hours Alert: Why NXP Semiconductors Stock Is Sliding

What’s Going On With Cancer Drug-Developer Nkarta Stock?